Sarepta Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) announced its participation in two upcoming virtual investor conferences. Management will engage in fireside chats at the BofA Securities Virtual Healthcare Conference on May 11, 2021, at 2:00 p.m. E.T., and the RBC 2021 Global Healthcare Conference on May 18, 2021, at 2:30 p.m. E.T. Both presentations will be webcast live and archived on Sarepta’s website for 90 days. Sarepta is dedicated to precision genetic medicine for rare diseases, holding a leadership position in Duchenne muscular dystrophy and limb-girdle muscular dystrophies.

CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:

• BofA Securities Virtual 2021 Healthcare Conference on Tuesday, May 11 at 2:00 p.m. E.T.
• RBC 2021 Global Healthcare Conference on Tuesday, May 18 at 2:30 p.m. E.T.

The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

When will Sarepta participate in the BofA Securities Virtual Healthcare Conference?

Sarepta will participate in the BofA Securities Virtual Healthcare Conference on May 11, 2021, at 2:00 p.m. E.T.

What is the date for Sarepta's presentation at the RBC 2021 Global Healthcare Conference?

Sarepta's presentation at the RBC 2021 Global Healthcare Conference is scheduled for May 18, 2021, at 2:30 p.m. E.T.

Where can I watch Sarepta's investor presentations?

You can watch Sarepta's investor presentations live on their website, which will also archive the events for 90 days.

What is Sarepta's focus in the field of healthcare?

Sarepta focuses on precision genetic medicine for rare diseases, specifically Duchenne muscular dystrophy and limb-girdle muscular dystrophies.

How many programs does Sarepta have in development?

Sarepta has over 40 programs in various stages of development.